This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Divine Skin Starts Lucrative Partnership With NutraOrigin, Expanding Into Nutritional Supplements

MIAMI BEACH, Fla., July 12, 2011 /PRNewswire/ -- Expanding into the lucrative market for nutritional supplements, biotech developer Divine Skin Inc. (DSKX) signed an exclusive deal with NutraOrigin, with 63 comprehensive formulas designed to be incorporated easily into any health regimen. With this agreement Divine Skin acquires exclusive access to NutraOrigin technologies and will receive 30% of all revenue generated with NutraOrigin products globally.

NutraOrigin's Omega line is the first brand of high-potency omega-3 fatty acids proven effective in large-scale clinical trials. In a recent double-blind study conducted for a US government agency, volunteers taking the NutraOrigin product improved reaction time and accuracy and reduced drowsiness and anxiety.

CEO Daniel Khesin said, "NutraOrigin fits perfectly into Divine Skin's model of performance-driven innovation and cutting-edge technology. In particular we are very excited about the significant advances in the fish oil category."

In the United States, manufacturers' revenues from vitamins and nutrients for human use total $9 billion per year, and fish oils alone top $280 million, according to an August 2010 report by the US Census Bureau.

Khesin also announced that Divine Skin has been actively working with NutraOrigin and has signed a deal with Whole Foods Market to launch NutraOrigin at retail. Last month, he announced a new pharmaceutical drug designed to compete with Tylenol, Advil, and aspirin.

About NutraOrigin

The cutting-edge nutritional supplements from NutraOrigin, manufactured in the United States, are the result of exhaustive research to maximize the role of nutritional compounds in humans.

The Omega line, demonstrated in trials to boost mental function, now comprises 28 SKUs. They include softgels with fish oil, krill oil, and other sources of omega-3 fatty acids, plus shakes in pleasant fruit flavors, gummies for kids, and oils for pets.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs